We examined the contribution of high blood pressure per se versus direct effects of the mineralocorticoid to kidney injury and inflammation in experimental DOCA-salt hypertension.
P-618 RENIN ANGIOTENSIN SYSTEM INHIBITION PREVENTS NATURALLY ADVANCED LEFT VENTRICULAR HYPERTROPHY VIA OXIDIZED STRESS SUPPRESSION
Norihisa Ito, Mitsuru Ohishi, Norio Komai, Koichi Yamamoto, Masaharu Kaibe, Takashi Takagi, Minako Terai, Yuji Tatara, Hiromi Rakugi, Toshio Ogihara. Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. We designed in vivo study using high aged spontaneously hypertensive rats (SHR) treated with angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) or their combined therapy to clarify the role of reactive oxygen species (ROS) for preventing left ventricular hypertrophy (LVH) and heart failure.
We used 30 male SHR aged 50 weeks (6 rats in each group). Each group was treated for 4 weeks using osmotic mini-pump with ACEI (temocaprilat 1mg/kg/day), ARB (olmesartan 0.2mg/kg/day), combined therapy (CT; temocaprilat 0.5mg/kg/day and olmesartan 0.1mg/kg/day) or hydralazine (H; 15mg/kg/day) to reduce equivalently blood pressure (BP) and with saline as control (C). We measured Heart/body weight (Heart Weight Index), BP by tail cuff method and plasma BNP. We measured histologically myocytes size by hematoxylin eosin stain and myocardial fibrotic area by Azan stain using computerized morphometry system (MacSCOPE ver2.2). We also measured p22phox, p47phox, gp91phox, TGF␤1 and FGF2 mRNA levels by real-time PCR and serum NOx by ELISA.
Heart/body weight (Heart Weight Index) treated with ARB (pϽ0.05) or CT (pϽ0.1) was reduced. Histological myocyte size in ACEI (pϽ0.05), ARB (pϽ0.01) or CT (pϽ0.001) and myocardial fibrosis in ACEI (pϽ0.05) or CT (pϽ0.01) was significantly reduced. Plasma BNP and NOx level in ACEI, ARB or CT was reduced (PϽ0.05). By real-time PCR, TGF␤1 mRNA in ACEI (pϽ0.05), ARB (pϽ0.05) or CT (pϽ0.01) or FGF2 mRNA in ACEI, ARB or CT (pϽ0.01) were significantly suppressed. The p22phox in ACEI (pϽ0.05), ARB (pϽ0.05) or CT (pϽ0.01), p47phox in ACEI (pϽ0.01 vs. C, pϽ0.05 vs. H), ARB (pϽ0.05 vs. C) or CT (pϽ0.01 vs. C, pϽ0.05 vs. H) or gp91phox in ACEI (pϽ0.01), ARB (pϽ0.01) or CT (pϽ0.005) were also significantly suppressed compared those in H or C.
We conclude that the dual inhibition of RAS showed additional beneficial effects on improvement of cardiac hypertrophy via ROS suppression even in naturally advanced LVH.
